These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 22795892)

  • 1. Group 1B phospholipase A₂ inactivation suppresses atherosclerosis and metabolic diseases in LDL receptor-deficient mice.
    Hollie NI; Konaniah ES; Goodin C; Hui DY
    Atherosclerosis; 2014 Jun; 234(2):377-80. PubMed ID: 24747111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice.
    Amor M; Bianco V; Buerger M; Lechleitner M; Vujić N; Dobrijević A; Akhmetshina A; Pirchheim A; Schwarz B; Pessentheiner AR; Baumgartner F; Rampitsch K; Schauer S; Klobučar I; Degoricija V; Pregartner G; Kummer D; Svecla M; Sommer G; Kolb D; Holzapfel GA; Hoefler G; Frank S; Norata GD; Kratky D
    Cardiovasc Diabetol; 2023 Nov; 22(1):327. PubMed ID: 38017481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted roles of Meg3 in cellular senescence and atherosclerosis.
    Cheng X; Shihabudeen Haider Ali MS; Baki VB; Moran M; Su H; Sun X
    Atherosclerosis; 2024 May; 392():117506. PubMed ID: 38518516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in spontaneous thrombolytic activity during progression of atherosclerosis in Apo
    Sato T; Yoshimura M; Sanda T; Hyodo K; Yamamoto J; Ishii H; Yamashita T
    Int J Clin Exp Pathol; 2018; 11(9):4521-4528. PubMed ID: 31949849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective modulator of nuclear receptor PPARγ with reduced adipogenic potential ameliorates experimental nephrotic syndrome.
    Bryant C; Rask G; Waller AP; Webb A; Galdino-Pitta MR; Amato AA; Cianciolo R; Govindarajan R; Becknell B; Kerlin BA; Neves FAR; Fornoni A; Agrawal S
    iScience; 2022 Apr; 25(4):104001. PubMed ID: 35310946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based identification of novel PPAR gamma ligands.
    da Silva FM; dos Santos JC; Campos JL; Mafud AC; Polikarpov I; Figueira AC; Nascimento AS
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5795-802. PubMed ID: 24075729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.
    de Almeida AR; Dantas AT; de Oliveira Gonçalves ME; Chêne C; Jeljeli M; Chouzenoux S; Thomas M; Cunha EGC; de Azevedo Valadares LD; de Melo Gomes JV; de Paula SKS; da Rocha Pitta MG; da Rocha Pitta I; de Melo Rêgo MJB; Pereira MC; Duarte ALBP; Abdalla DSP; Nicco C; Batteux F; da Rocha Pitta MG
    Inflammopharmacology; 2024 Feb; 32(1):433-446. PubMed ID: 37477795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes to Urinary Proteome in High-Fat-Diet
    Hua Y; Meng W; Wei J; Liu Y; Gao Y
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure and conformational analysis of 2-hy-droxy-3-(2-methyl-prop-1-en-1-yl)naphthalene-1,4-dione.
    Alcantara Emiliano S; Welma Duarte Silva S; Alves Pereira M; R Dos Santos Malta V; Luciano Balliano T
    Acta Crystallogr E Crystallogr Commun; 2016 Feb; 72(Pt 2):188-90. PubMed ID: 26958384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A facile synthesis and antimicrobial activity evaluation of sydnonyl-substituted thiazolidine derivatives.
    Shih MH; Xu YY; Yang YS; Lin GL
    Molecules; 2015 Apr; 20(4):6520-32. PubMed ID: 25871371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
    Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA
    PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
    Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
    Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy.
    Sukhovershin RA; Yepuri G; Ghebremariam YT
    Methodist Debakey Cardiovasc J; 2015; 11(3):166-71. PubMed ID: 26634024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-atherosclerotic effect of pioglitazone--the first evidence of the role of triglyceride/HDL ratio].
    Császár A
    Lege Artis Med; 2011 Feb; 21(2):105-11. PubMed ID: 21710708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of new thiazolidine derivatives LPSF/GQ-02 and LPSF/GQ-16 on atherosclerotic lesions in LDL receptor-deficient mice (LDLR(-/-)).
    Soares E Silva AK; de Oliveira Cipriano Torres D; Santos Rocha SW; dos Santos Gomes FO; dos Santos Silva B; Donato MA; Raposo C; Santos AC; de Lima Mdo C; Galdino SL; da Rocha Pitta I; de Souza JR; Peixoto CA
    Cardiovasc Pathol; 2013; 22(1):81-90. PubMed ID: 22795892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic LPSF/GQ-02 treatment attenuates inflammation and atherosclerosis development in LDLr
    Silva AKSE; Gomes FODS; Santos Silva BD; Ribeiro EL; Oliveira AC; Araújo SMDR; de Lima IT; Oliveira AGV; Rudnicki M; Abdalla DSP; Lima MDCA; Pitta IDR; Peixoto CA
    Eur J Pharmacol; 2016 Nov; 791():622-631. PubMed ID: 27693798
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.